Candriam Equities L Biotechnology Class I EUR Hedged Cap Fonds
|
WKN DE: A1432M / ISIN: LU1006082199
management charges
administration fee | % |
custodian fee | % |
management charge | 0,60 % |
total expense ratio (ter) | 0,80 |
issue charge | 0,00 % |
derivatives#masterdata#headline
issue date | 04.12.2015 |
benchmark | NASDAQ Biotechnology |
domicile | Luxembourg |
fund manager
fund manager | Linden Thomson, Servaas Michielssens |
buy information
initial minimum savings amount | 0,00 |
capital forming savings possible? | no |
investment company information
funds#investmentcompanyinformation#adress |
Candriam Candriam Luxembourg L – 8009 Strassen |